| scholarly article | Q13442814 |
| P50 | author | Kaj Blennow | Q28321550 |
| Oskar Hansson | Q30533735 | ||
| P2093 | author name string | Karin Nilsson | |
| John C van Swieten | |||
| Christer Nilsson | |||
| Maria Landqvist Waldö | |||
| Shorena Janelidze | |||
| Lieke H Meeter | |||
| Alexander F Santillo | |||
| P2860 | cites work | Classification of primary progressive aphasia and its variants | Q24594803 |
| Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia | Q24598142 | ||
| The genetics and neuropathology of frontotemporal lobar degeneration | Q24615201 | ||
| Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS | Q24633692 | ||
| A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD | Q24634583 | ||
| Clinical review. Frontotemporal dementia | Q26999462 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Focal cortical presentations of Alzheimer's disease | Q28250737 | ||
| Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 | Q28253639 | ||
| Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 | Q28253651 | ||
| Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17 | Q28274687 | ||
| Comparison of family histories in FTLD subtypes and related tauopathies | Q28286447 | ||
| Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria | Q29614410 | ||
| Regulation of angiogenesis by hypoxia: role of the HIF system | Q29619187 | ||
| Mild cognitive impairment as a diagnostic entity | Q29619568 | ||
| How to diagnose dementia with Lewy bodies: state of the art. | Q30999035 | ||
| Frontotemporal dementia mimicking dementia with Lewy bodies | Q33370063 | ||
| Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration | Q33610029 | ||
| Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review | Q33726688 | ||
| Clinicopathological correlates in frontotemporal dementia | Q34345893 | ||
| Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography | Q34435040 | ||
| Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia | Q34746995 | ||
| Assessment of CSF Aβ42 as an aid to discriminating Alzheimer's disease from other dementias and mild cognitive impairment: a meta-analysis of 50 studies | Q35217859 | ||
| Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis | Q35750755 | ||
| Increased CSF biomarkers of angiogenesis in Parkinson disease | Q35825166 | ||
| Mutation in the tau gene in familial multiple system tauopathy with presenile dementia | Q36507684 | ||
| Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia | Q37024895 | ||
| Frontotemporal dementia: clinicopathological correlations | Q37069848 | ||
| The discovery of the placental growth factor and its role in angiogenesis: a historical review | Q37196288 | ||
| Neurofilament light chain: a biomarker for genetic frontotemporal dementia | Q37208495 | ||
| CSF biomarkers in frontotemporal lobar degeneration with known pathology | Q37253492 | ||
| Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia | Q37304614 | ||
| Oxidative stress in angiogenesis and vascular disease | Q37535220 | ||
| Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder | Q37676938 | ||
| Tau and p-tau as CSF biomarkers in dementia: a meta-analysis | Q37845820 | ||
| Imaging and fluid biomarkers in frontotemporal dementia. | Q38670219 | ||
| Placental growth factor: What hematologists need to know | Q38823169 | ||
| The clinical spectrum of sporadic and familial forms of frontotemporal dementia. | Q38825197 | ||
| Psychiatric symptoms and their psychosocial consequences in frontotemporal dementia | Q40368927 | ||
| Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia | Q40777128 | ||
| Tau is a candidate gene for chromosome 17 frontotemporal dementia | Q42456776 | ||
| Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. | Q43491607 | ||
| Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. | Q46043966 | ||
| Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia | Q46080645 | ||
| Type-dependent oxidative damage in frontotemporal lobar degeneration: cortical astrocytes are targets of oxidative damage | Q46239199 | ||
| Temporal profile of angiogenesis and expression of related genes in the brain after ischemia | Q46508396 | ||
| Neuropsychiatric characteristics of PiB-negative subcortical vascular dementia versus behavioral variant frontotemporal dementia | Q48047509 | ||
| Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop | Q48342894 | ||
| Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling | Q48636650 | ||
| A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study | Q48791547 | ||
| Antemortem diagnosis of frontotemporal lobar degeneration | Q48957288 | ||
| Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases | Q49392411 | ||
| Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders. | Q50940972 | ||
| Frontotemporal dementia. | Q53268278 | ||
| Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum. | Q53396239 | ||
| A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes. | Q53396502 | ||
| Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease. | Q54792772 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | frontotemporal dementia | Q18592 |
| biomarker | Q864574 | ||
| P304 | page(s) | 863-872 | |
| P577 | publication date | 2019-05-01 | |
| P1433 | published in | Annals of clinical and translational neurology | Q27725312 |
| P1476 | title | CSF placental growth factor - a novel candidate biomarker of frontotemporal dementia | |
| P478 | volume | 6 |
Search more.